REGN
Regeneron Pharmaceuticals Inc
$755.13
-0.54%
-4.11
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
78.2B
Enterprise value
70.5B
Trailing PE
18.815357
Forward PE
12.688324
PEG Ratio
-4.01798914
Enterprise to EBITDA
14.998
Enterprise to revenue
4.54
Price to book MRQ
2.4556231
Price to sales TTM
5.017819
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
15.5B
EBITDA
5.4B
Diluted EPS TTM
40.24
Total Cash (MRQ)
8.0B
Current ratio (MRQ)
3.335
Operating Cash Flow (TTM)
4.7B
REGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
